SkinStylus has received FDA clearance for the improvement of periorbital wrinkles across all skin types, adding a new indication to its radiofrequency microneedling platform. The clearance expands the device's addressable market into a high-demand anatomical zone where practices already perform filler and neuromodulator work.
The periorbital region has historically been challenging for RF microneedling due to proximity to the eye and variable skin thickness, making this clearance clinically and commercially significant. The all-skin-type language removes the need for separate protocols by Fitzpatrick classification, simplifying patient selection and treatment planning.